Aurinia Pharmaceuticals (AUPH) Just Turned Profitable — Is This the Most Undervalued Biotech Stock of 2025?
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is a late-stage biopharmaceutical company headquartered in Victoria, British Columbia, with U.S. commercial operations…